Metabolic HealthGLP-1 Drugs Work Better When Paired With Exercise and Nutrition Support
GLP-1 receptor agonists and dual GIP/GLP-1 drugs like tirzepatide are powerful tools for weight loss, but they can reduce lean body mass alongside fat. This review argues that pairing these medications with structured exercise, optimized nutrition, and behavioral support — what the authors call 'metabolic rehabilitation' — can preserve muscle quality, protect bone health, and improve cardiovascular fitness in ways the drugs alone cannot. The authors stress that reduced lean mass on a DXA scan doesn't necessarily mean lost muscle function, since no clinical trial has shown these drugs impair strength. Still, integrating exercise and nutrition into obesity care creates additive benefits and addresses gaps that medication alone leaves open. The review proposes a practical framework for combining both approaches in clinical practice.
